Carlyle Puts Up $4B For J&J's Blood-Testing Unit

Law360, New York (January 16, 2014, 12:48 PM EST) -- Private equity powerhouse The Carlyle Group LP announced Thursday that it will acquire Johnson & Johnson's blood-testing diagnostics unit, Ortho-Clinical Diagnostics Inc., for $4.15 billion.

Raritan, N.J.-based Ortho-Clinical Diagnostics manufactures blood-testing tools and equipment for hospitals, laboratories and blood centers worldwide. Carlyle said it plans to operate OCD as a stand-alone business after the transaction is finalized. OCD operates in 130 countries and maintains its manufacturing operations in Rochester, N.Y.; Pompano Beach, Fla.; and Pencoed, Wales.

Carlyle said that equity for the transaction comes from Carlyle...
To view the full article, register now.